AFib - Nursing Case Study

Pathophysiology

• Primary mechanism: Atrial fibrillation (AFib) is primarily driven by disorganized electrical signals in the atria, resulting in rapid and irregular atrial contractions. This electrical chaos is often due to ectopic foci, particularly around the pulmonary veins, which overwhelm the sinus node's pacing function.

• Secondary mechanism: The irregular atrial activity leads to ineffective atrial contraction and loss of atrial kick, reducing ventricular filling and cardiac output. This hemodynamic alteration is exacerbated by the potential for rapid ventricular response due to irregular AV node conduction.

• Key complication: The stasis of blood in the fibrillating atria promotes thrombus formation, particularly in the left atrial appendage, significantly increasing the risk of embolic stroke. Additionally, persistent AFib can lead to tachycardia-induced cardiomyopathy, further compromising cardiac function.

Patient Profile

Demographics:

67-year-old male, retired chemical engineer

History:

• Key past medical history: Hypertension, Type 2 Diabetes Mellitus, Chronic Kidney Disease (Stage 3), Previous Myocardial Infarction

• Current medications: Metoprolol, Warfarin, Metformin, Lisinopril, Atorvastatin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Palpitations and shortness of breath

• Key symptoms: Irregular heartbeat, fatigue, dizziness, chest discomfort, swollen ankles

• Vital signs: Blood pressure 160/95 mmHg, Heart rate 140 bpm irregular, Respiratory rate 24 breaths per minute, Oxygen saturation 88% on room air, Temperature 98.6°F

Section 1

New Diagnostic Results:

Upon admission, the patient underwent a series of diagnostic tests to further evaluate his condition and guide treatment decisions. An electrocardiogram (ECG) confirmed the presence of atrial fibrillation with a rapid ventricular response, consistent with the patient's symptoms. The echocardiogram revealed moderate left ventricular hypertrophy and an ejection fraction of 35%, indicating compromised cardiac function likely exacerbated by the rapid heart rate. The patient's lab results showed a significant elevation in serum creatinine at 2.3 mg/dL, reflecting a decline in renal function, possibly due to decreased perfusion from the compromised cardiac output. B-type natriuretic peptide (BNP) levels were markedly elevated at 1,500 pg/mL, suggesting significant cardiac stress and potential heart failure exacerbation.

In addition, the patient's coagulation profile indicated an international normalized ratio (INR) of 3.2, which, while within the therapeutic range for preventing thromboembolism, raised concerns for potential bleeding risk, especially in the context of renal impairment. Chest X-ray findings showed mild pulmonary congestion and cardiomegaly, correlating with the patient's reported shortness of breath and oxygen desaturation. Arterial blood gas analysis revealed a respiratory alkalosis with a pH of 7.48, PaCO2 of 32 mmHg, and PaO2 of 60 mmHg, indicating hypoxemia and compensatory hyperventilation.

These diagnostic results underscore the complexity of the patient's condition, necessitating a nuanced approach to management. The interplay between AFib, heart failure, and renal impairment poses a significant challenge in balancing anticoagulation, rate control, and fluid management. The healthcare team must carefully weigh the risks and benefits of potential interventions, considering the patient's comorbidities and the potential for adverse effects. As such, a multidisciplinary approach involving cardiology, nephrology, and pharmacy consultations is essential to optimize outcomes and mitigate the risk of further complications.

Section 2

Change in Patient Status:

Following the initial assessment and diagnostic evaluation, the patient experienced a sudden change in clinical status overnight. The nursing team noted an acute increase in respiratory distress, with the patient becoming tachypneic at a rate of 28 breaths per minute and exhibiting labored breathing. Oxygen saturation levels dropped further to 84% on room air, prompting the initiation of supplemental oxygen via a non-rebreather mask at 10 L/min. Auscultation of the lungs revealed diffuse crackles, indicating worsening pulmonary congestion.

Simultaneously, the patient's blood pressure decreased to 88/56 mmHg, raising concerns about hemodynamic instability. The heart rate remained elevated at 130 beats per minute, despite attempts at rate control with beta-blockers. Repeat laboratory tests showed a further increase in serum creatinine to 2.8 mg/dL, suggesting progressive renal compromise. Additionally, the INR had risen to 3.6, heightening the risk of bleeding complications. The patient's mental status became altered, with periods of confusion and disorientation, possibly due to hypoperfusion or hypoxia.

Given these developments, the healthcare team faced critical decisions regarding the management of the patient's atrial fibrillation, heart failure, and renal impairment. The current treatment plan required urgent reassessment to address the exacerbation of heart failure symptoms and potential cardiogenic shock. Consideration for intravenous diuretics was balanced against the risk of further renal deterioration. The decision to initiate an inotropic agent to support cardiac output was also debated, with close monitoring of potential adverse effects. Moreover, the risks and benefits of continuing anticoagulation therapy were re-evaluated in light of the elevated INR and renal status. These changes necessitated immediate collaboration among the cardiology, nephrology, and critical care teams to stabilize the patient and prevent further complications.

Section 3

New Complications:

As the healthcare team grappled with the patient's deteriorating condition, new complications emerged that further complicated the clinical picture. Despite the application of the non-rebreather mask, the patient's oxygen saturation levels continued to fluctuate between 82% and 86%, prompting concerns about acute respiratory failure. A chest X-ray was ordered stat and revealed bilateral infiltrates consistent with pulmonary edema, confirming the suspicion of acute decompensated heart failure. Meanwhile, the patient's renal function continued to decline, with a creatinine level peaking at 3.1 mg/dL, indicating acute kidney injury likely due to cardiorenal syndrome.

In addition to respiratory and renal challenges, the patient's neurological status worsened, with an increasing frequency of confusion and episodes of agitation. A CT scan of the brain was performed to rule out any acute intracranial events, which fortunately showed no signs of hemorrhage or ischemia. However, the elevated INR added complexity to the management of anticoagulation therapy, posing a significant risk for potential bleeding events. The team had to weigh the risk of thrombosis due to atrial fibrillation against the high bleeding risk, especially considering the altered mental status that could mask signs of a potential intracranial bleed.

As these new complications unfolded, the interdisciplinary team convened urgently to reassess the management approach. The decision was made to cautiously initiate a low-dose inotropic infusion to support cardiac output while closely monitoring hemodynamic parameters and renal function. Simultaneously, a nephrology consult was requested to explore options for renal support, and a critical care specialist was involved to optimize respiratory management. These strategic interventions aimed to stabilize the patient and mitigate the risk of further deterioration, emphasizing the need for vigilant monitoring and rapid response to any additional changes in the patient's status.

Section 4

As the interdisciplinary team implemented the new management strategies, close attention was paid to the patient's response to the interventions. Despite the initiation of the low-dose inotropic infusion, the patient's hemodynamic status remained tenuous. Blood pressure readings fluctuated between hypotensive episodes, with systolic pressures dropping to the low 80s, and periods of unstable hypertension reaching 160/100 mmHg. This erratic blood pressure pattern indicated potential autonomic dysregulation, complicating the titration of medications aimed at supporting cardiac output. Concurrently, the renal consult led to the initiation of continuous renal replacement therapy (CRRT) in an attempt to address the worsening renal function and mitigate fluid overload contributing to the pulmonary edema.

Unfortunately, as the team continued to monitor the patient's neurological status, the confusion and agitation escalated into a full-blown delirium. The patient became increasingly uncooperative, pulling at lines and attempting to get out of bed, which posed a significant safety risk. Sedation was cautiously administered, but the team had to remain vigilant to avoid exacerbating the already delicate balance of respiratory function. In the midst of this, repeat laboratory tests revealed a critical drop in hemoglobin to 7.8 g/dL, suggesting a possible occult bleed, likely exacerbated by the elevated INR and anticoagulation therapy. This new finding necessitated an urgent reassessment of the anticoagulation strategy, balancing the imminent risk of thromboembolic events against the clear signs of bleeding.

These developments demanded a rapid recalibration of the clinical approach. The team decided to hold anticoagulation temporarily to investigate the source of bleeding, while cautiously administering blood products to stabilize hemoglobin levels. A gastroenterology consult was requested to explore potential gastrointestinal sources of bleeding, and the critical care team intensified monitoring, prepared to respond swiftly to any further complications. This multifaceted approach underscored the complexity of managing a patient with such intertwined and escalating complications, requiring precise coordination and advanced clinical reasoning to navigate the evolving clinical landscape.

Section 5

As the interdisciplinary team grappled with the patient's complex clinical picture, new diagnostic results further complicated the situation. A bedside endoscopy performed by the gastroenterology team revealed a bleeding gastric ulcer, likely precipitated by the combination of anticoagulation therapy and stress-related mucosal disease. This finding necessitated immediate intervention to control the bleeding and prevent further hemodynamic instability. The team administered intravenous proton pump inhibitors and considered endoscopic intervention to achieve hemostasis. Meanwhile, the hematology consult advised on the cautious reintroduction of anticoagulation once the bleeding was under control, given the high risk of thromboembolic complications due to the patient's atrial fibrillation and fluctuating INR levels.

In addition to the gastrointestinal findings, a follow-up echocardiogram demonstrated worsening left ventricular function, with an ejection fraction now reduced to 30%. This deterioration suggested further compromise of cardiac output and might explain the persistent episodes of hypotension despite inotropic support. The cardiac team recommended optimizing heart failure management, considering the addition of a beta-blocker once the patient's hemodynamic status stabilized, to improve long-term cardiac function and rhythm control.

Simultaneously, the patient's neurological status continued to decline, with episodes of delirium becoming more frequent and severe. A CT scan of the head was performed to rule out any acute intracranial events, which returned negative. The team hypothesized that the delirium was multifactorial, related to metabolic derangements, medication effects, and prolonged ICU stay. As part of a comprehensive delirium management strategy, the team emphasized non-pharmacological interventions, including regular reorientation, minimizing sleep disruptions, and involving the family in care. These measures aimed to address the neurological complications while balancing the need for sedation to ensure patient safety. This complex interplay of complications demanded ongoing critical evaluation and dynamic adaptation of the treatment plan to navigate the patient's precarious clinical course.